Chronicle Journal: Finance

BRIEF-Redhill Biopharma and Intelgenx submit new drug application to FDA for Rizaport® for migraines

* Redhill Biopharma and Intelgenx submit new drug application to FDA for Rizaport® for migraines
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.